Moreover, cytokines (such as APRIL) produced by neutrophils in patients with lymphoproliferative disorders increase tumor aggressiveness [48], while others (i.e. IFN-γ, -α, IL-4, -8) can inhibit apoptosis of malignant B cells in vitro[49]–[52]. The gene discussed is IL4; the disease is lymphoproliferative syndrome.